Natixis’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,652,200
Closed -$38.7M 1007
2024
Q1
$38.7M Buy
3,652,200
+456,000
+14% +$3.99M 0.2% 86
2023
Q4
$25.7M Sell
3,196,200
-439,000
-12% -$3.2M 0.19% 117
2023
Q3
$30M Buy
3,635,200
+235,200
+7% +$2.03M 0.23% 95
2023
Q2
$27.2M Sell
3,400,000
-4,600,000
-58% -$33.9M 0.22% 101
2023
Q1
$64.7M Sell
8,000,000
-7,817,975
-49% -$62.8M 0.58% 29
2022
Q4
$99.3M Buy
15,817,975
+7,817,975
+98% +$54.6M 0.56% 45
2022
Q3
$55.1M Buy
8,000,000
+7,469,000
+1,407% +$51.9M 0.26% 63
2022
Q2
$4.44M Sell
531,000
-57,927
-10% -$810K 0.02% 473
2022
Q1
$13.5M Buy
+588,927
New +$14.4M 0.05% 349
2021
Q1
Sell
-716,606
Closed -$14.9M 1071
2020
Q4
$14.9M Buy
+716,606
New +$13.4M 0.05% 316
2017
Q3
Sell
-10,435
Closed -$181K 1250
2017
Q2
$181K Buy
+10,435
New +$125K ﹤0.01% 754

Other funds holding BHC

Natixis's BHC Position: Q2 2024 in Review

Natixis sold out of Bausch Health (BHC) in Q2 2024, closing a stake of 3,652,200 shares — an estimated $38.7M sold.

Natixis first reported a position in BHC in Q2 2017 and held it in 11 quarters. The position peaked at $99.3M in Q4 2022. 234 funds tracked by Wall St. Rank hold BHC as of Q2 2024.

  • Natixis reported no remaining Bausch Health position as of Q2 2024 after selling out during the quarter.
  • Natixis sold 3,652,200 Bausch Health shares in Q2 2024, an estimated $38.7M.
  • Natixis first reported a position in Bausch Health in Q2 2017 and held it in 11 quarters.
  • Natixis's Bausch Health position peaked at $99.3M in Q4 2022.
  • 234 funds tracked by Wall St. Rank held Bausch Health as of Q2 2024.

Based on Natixis's 13F filing for Q2 2024, filed 13 Aug 2024.